PIERRE, S.D. –– American Cancer Society Cancer Action Network (ACS CAN) advocates will arrive at the Statehouse Wednesday for their annual Day at the Capitol.
La siguiente es una declaración del Director Senior de Relaciones Gubernamentales de Nueva York de la Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN, por sus siglas en inglés), Michael Davoli:
“Tras el discurso sobre la situación del Estado de la Gobernadora Hochul a principios de esta semana, donde en contadas ocasiones se mencionaron el acceso y los costos de la atención médica, los defensores de los pacientes tienen la esperanza de que la gobernadora priorice los bajos costos de la atención médica en su propuesta de presupuesto ejecutivo para el año fiscal 2025-26.
TALLAHASSEE, Florida – Mientras los legisladores de Florida comienzan las reuniones de los comités para la sesión de 2025, la Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN) les pide que prioricen la reducción del s
CHEYENNE, Wyo. – As legislative business convenes today in the state capitol, lawmakers must prioritize access to health care so that tens of thousands of Wyomingites can continue to lead healthy and happy lives and have the best chance to avoid, detect and defeat cancer.
As Governor Daniel McKee prepares for his State of the State address, patient advocates are highlighting the results of a new report by the American Cancer Society Cancer Action Network (ACS CAN), which found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them.
A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them.
A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them.
ATLANTA, Ga. – As Georgia lawmakers reconvene for the 2025 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) looks forward to working with them to prioritize legislation to ease the burden of cancer on Georgians.